- Home
- EUDA vs ABVC Comparison
EUDA vs ABVC Comparison
Compare EUDA & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EUDA | ABVC |
|---|---|---|
| Founded | 2021 | 2015 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.7M | 58.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | EUDA | ABVC |
|---|---|---|
| Price | $2.27 | $2.23 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 36.8K | ★ 60.8K |
| Earning Date | 01-01-0001 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $5,160,280.00 | $797,916.00 |
| Revenue This Year | $137.25 | $735.18 |
| Revenue Next Year | $361.43 | N/A |
| P/E Ratio | $313.71 | ★ N/A |
| Revenue Growth | ★ 83.73 | 56.52 |
| 52 Week Low | $1.03 | $0.40 |
| 52 Week High | $6.30 | $5.48 |
Technical Indicators
Market Signals| Indicator | EUDA | ABVC |
|---|---|---|
| Relative Strength Index (RSI) | 39.34 | 33.04 |
| Support Level | $2.81 | $2.06 |
| Resistance Level | $3.21 | $2.87 |
| Average True Range (ATR) | 0.31 | 0.19 |
| MACD | -0.06 | -0.05 |
| Stochastic Oscillator | 3.42 | 19.32 |
Price Performance
Historical ComparisonAbout EUDA EUDA Health Holdings Limited
EUDA Health Holdings Ltd is a non-invasive healthcare company across Southeast Asia and China. The Company has two reportable segments: property management services and holistic wellness consumer products and services. Key revenue is generated from property management services that include common area property management services that contain cleaning, landscaping, public facilities maintenance and other traditional services and also include security property management services provided to all tenants and property owners.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.